Get the app
public
ios_share
OncoPharm
chevron_right
Dual TKI Use & Frontline Dara
May 10, 2018
22:03
forum
Ask episode
play_arrow
Play
view_agenda
Chapters
auto_awesome
Transcript
info_circle
Episode notes
Recent FDA updates are discussed including combined use of BRAF & MEK inhibitors, frontline daratumumab (10:20), and your next P & T monograph drug to review.